AU3505397A - Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same - Google Patents
Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the sameInfo
- Publication number
- AU3505397A AU3505397A AU35053/97A AU3505397A AU3505397A AU 3505397 A AU3505397 A AU 3505397A AU 35053/97 A AU35053/97 A AU 35053/97A AU 3505397 A AU3505397 A AU 3505397A AU 3505397 A AU3505397 A AU 3505397A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- same
- directed against
- immunodeficiency virus
- human immunodeficiency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2039696P | 1996-06-25 | 1996-06-25 | |
US60020396 | 1996-06-25 | ||
US2064796P | 1996-06-27 | 1996-06-27 | |
US60020647 | 1996-06-27 | ||
PCT/US1997/011093 WO1997049424A1 (en) | 1996-06-25 | 1997-06-25 | Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3505397A true AU3505397A (en) | 1998-01-14 |
Family
ID=26693384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU35053/97A Abandoned AU3505397A (en) | 1996-06-25 | 1997-06-25 | Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3505397A (en) |
WO (1) | WO1997049424A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743594B1 (en) | 1995-06-06 | 2004-06-01 | Human Genome Sciences, Inc. | Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5) |
US6025154A (en) | 1995-06-06 | 2000-02-15 | Human Genome Sciences, Inc. | Polynucleotides encoding human G-protein chemokine receptor HDGNR10 |
DE69637890D1 (en) | 1995-06-07 | 2009-05-14 | Progenics Pharm Inc | MONOCLONAL ANTIBODY FOR THE INHIBITION OF HIV-1-HÜLLGYKOPROTEIN-MEDIATED MEMBRANE FUSION |
US7118859B2 (en) | 1996-01-17 | 2006-10-10 | Progenics Pharmaceuticals, Inc. | Methods for inhibiting HIV-1 infection |
AU766675B2 (en) * | 1998-03-30 | 2003-10-23 | Northwest Biotherapeutics, Inc. | Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis |
US6610834B1 (en) * | 1998-11-18 | 2003-08-26 | Peter I. Lobo | Human IgM antibodies to chemokine receptors |
US7138119B2 (en) | 2000-09-15 | 2006-11-21 | Progenics Pharmaceuticals, Inc. | Compositions and methods for inhibition of HIV-1 infection |
US7175988B2 (en) | 2001-02-09 | 2007-02-13 | Human Genome Sciences, Inc. | Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
US7393934B2 (en) | 2001-12-21 | 2008-07-01 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor (CCR5) HDGNR10 |
US7122185B2 (en) | 2002-02-22 | 2006-10-17 | Progenics Pharmaceuticals, Inc. | Anti-CCR5 antibody |
WO2005105841A2 (en) | 2004-03-12 | 2005-11-10 | Human Genome Sciences, Inc. | Human g-protein chemokine receptor (ccr5) hdgnr10 |
WO2012178137A1 (en) | 2011-06-24 | 2012-12-27 | Gillies Stephen D | Light chain immunoglobulin fusion proteins and methods of use thereof |
KR102531889B1 (en) | 2016-06-20 | 2023-05-17 | 키맵 리미티드 | Anti-PD-L1 and IL-2 cytokines |
-
1997
- 1997-06-25 WO PCT/US1997/011093 patent/WO1997049424A1/en active Application Filing
- 1997-06-25 AU AU35053/97A patent/AU3505397A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1997049424A1 (en) | 1997-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5155398A (en) | Anti-ccr5 antibodies and methods of use therefor | |
AU3727695A (en) | Compositions and methods for the abrogation of cellular proliferation utilizing the human immunodeficiency virus vpr protein | |
AU1866895A (en) | Human monoclonal antibodies to herpes simplex virus and methods therefor | |
AU5422696A (en) | Nox catalyst and method of using the same | |
AU4397297A (en) | Antibody against human parathormone related peptides | |
AU4648697A (en) | Methods and devices for preparing protein concentrates | |
AU1108695A (en) | Aza-4-iminoquinolines, methods of preparing them and their use | |
AU2507397A (en) | Multivalent and multispecific antigen-binding protein | |
AU7250098A (en) | Anastomosis system and method of use | |
AU4453896A (en) | Activation of t-cells by modified, antigenic immunoglobulins | |
AU6124196A (en) | Novel dolastatin derivatives, their preparation and use | |
AU3505397A (en) | Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same | |
AU7198291A (en) | Human monoclonal antibodies against rabies viruses, the production and the use thereof | |
AU2419595A (en) | Recombinant human immunodeficiency virus vector and process for producing the same | |
AU5641798A (en) | Artificial antibodies, method of producing the same and use thereof | |
AU7676300A (en) | Human anti-adipocyte monoclonal antibodies and their use | |
EP0805161A4 (en) | (1-3)-beta-d-glucan-binding protein, antibody that recognizes the protein, and use of the protein and antibody | |
AU6372496A (en) | Absorbent material, absorbent body made of the material, and method for the preparation of the material | |
AU7203194A (en) | Bispecific human monoclonal antibodies specific for human immunodeficiency virus | |
EP0711310A4 (en) | Human antibodies against varicella-zoster virus | |
EP0919576A4 (en) | Novel copolymer, process for the preparation of the same, and use thereof | |
AU5923998A (en) | 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same | |
AU3241895A (en) | Apoptosis related protein bcl-y, and methods of use thereof | |
AU1538497A (en) | Anti-gp46 antibodies and fragments thereof and their use | |
AU2247095A (en) | Cellular immune response-specific antigens and uses therefor |